Medicine Overview of Dilnip-Trio Tablet
Nausea, Altered taste, Stomach upset, Diarrhoea, Dizziness, Headache, Flushing (sense of warmth in the face, ears, neck and trunk), Increased blood uric acid, Increased blood lipid level, Decreased sodium level in blood, Decreased magnesium level in blood, Decreased blood pressure, Numbness of extremity.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Dilnip-Trio Tablet is to be taken with food.
Dilnip-Trio Tablet is a combination of three medicines: Telmisartan, Cilnidipine and Chlorthalidone. Telmisartan is an angiotensin receptor blocker (ARB) and Cilnidipine is a calcium channel blocker (CCB). They work by widening and relaxing the blood vessels, thereby lowering blood pressure. Chlorthalidone is a diuretic which removes extra water and certain electrolytes from the body through urine. Over time it also works by relaxing blood vessels and improving blood flow.
In Depth Information on Dilnip-Trio Tablet
Dilnip-Trio Tablet related warnings
Taking Chlorthalidone with alcohol may have additive effects in lowering your blood pressure. You may experience headache, dizziness, lightheadedness, fainting, and/or changes in pulse or heart rate.
WEIGH RISKS VS BENEFITS
Dilnip-Trio Tablet is unsafe to use during pregnancy.
There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.
No information is available on the use of Dilnip-Trio Tablet during lactation. Please consult your doctor.
Dilnip-Trio Tablet may make you feel dizzy, sleepy, tired, or decrease alertness. If this happens, do not drive.
Dilnip-Trio Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Dilnip-Trio Tablet may be needed. Please consult your doctor.
Use of Dilnip-Trio Tablet is not recommended in these patients.
Dilnip-Trio Tablet should be used with caution in patients with liver disease. Dose adjustment of Dilnip-Trio Tablet may be needed. Please consult your doctor.
Use of Dilnip-Trio Tablet is not recommended in patients with severe liver disease.
No Patient Concerns found for this medicine
User Submitted Feedback For Dilnip-Trio Tablet
Patients taking Dilnip-Trio Tablet How much was the improvement? What are you using Dilnip-Trio Tablet for?
Survey Participants: 6
“The following are the results of on-going survey on 1mg.com for Dilnip-Trio Tablet. These results only indicate the perceptions of the website users. Please base your medical decisions only on the advice of a doctor or a registered medical professional.”
One of the following vendor pharmacies will deliver Dilnip-Trio Tablet: PPR, WHL, PVP, BIO, RHL, IAD, BBS, RUS, MDH, QLF, VNS, NXG, RWP, GPP, NSL, NTB, ZVP, KMC, PEN, PWN, NVL, EMB, DGN, BLE, ATP, SWP, HIP, HPC, JIV, BTM, DLP, MLC, AYM, NNH, EVP, SLN, NDP, BAP, DYG, RKS, STA, SSA, VDH, ABP, GTC, LHA, KHC, ENP, TRP, NVY, RPI, HAT, JVN, ESY, ANT, ATL, CLT, INC, PTI, GBL, LCC, 9T9, GHR, MAX, DHR, SHC, HZF, OIP, MAM, USF, BHM, SRG, SJP, GNC, MMS, UMP, WSI, MSD, RSA, RDR, TNH, DFP, PNT, AMR, DVH, SBA, RPP, ADT, MPC, PLT, OWP, QTM, JVO, SHD, HGI, RDH, PRN, HTS, DPL, EQN, SVH, BAL, ZEL, DPP, HBV, SYN, VRS, SWA, MAK, BSN, AYU, ARD, KHH, P2P, TFP, BDN, SHP, OLT, HEX, IPL, SCH, SGH, HMP, BHP, MDO, SGC, AAY, AGT, GTK, THP, FGH, RSS, PMA, AAR, TOM, RHW, HSP, RJH, JSL, BMJ, HNP, SDM, SAF, SBL, GPT, OHM